The update included background on the relationship between GLP-1 receptor agonists and endoscopic procedures, followed by clinical strategies for patients taking these medications.
The American Gastroenterological Association has issued a rapid clinical practice update on the use of glucagon-like peptide 1 receptor agonists prior to endoscopy.
"Many facilities and medical centers are now struggling to revise preprocedural protocols for patients taking this class of medications despite the lack of high-level evidence regarding how to proceed," the panelists wrote in.
The above findings"imply an increased risk of aspiration in patients receiving GLP-1 receptor agonist medications who present for procedures that require sedation," the panelists wrote, but more data are needed to support this hypothesis.Residual liquid in the stomach, at least, is"less of an issue," according to the update, because"it is easily removed during an esophagogastroduodenoscopy, and this is the first maneuver performed by endoscopists on entering the stomach.
Diabetes Mellitus Type Ii Type 2 Diabetes Type 2 DM T2DM T2D GLP-1 Receptor Agonists Glucagon-Like Peptide-1 Receptor Agonists Receptors Endoscopy Acute Pain Pain Management Perioperative Stomach Aspiration Colorectal Cancer Colorectal Cancer (CRC)
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GLP-1 Receptor Agonists Don't Raise Thyroid Cancer RiskA cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.
Read more »
How these weight loss drugs offer benefits beyond the scaleGLP-1 receptor agonist drugs named the 2023 Breakthrough of the Year
Read more »
EU Investigation Finds No Link Between GLP-1 Drugs and Suicide RiskHealth regulators in the European Union have concluded a nine-month investigation and found no evidence of a causative link between GLP-1 drugs and an increased risk of suicide or suicidal ideation. This should provide reassurance for individuals taking drugs like Ozempic to treat type 2 diabetes and/or obesity.
Read more »
GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study SuggestsI'm a Texas native covering the latest trends in tech, science and healthcare through explainer pieces on the breaking news team. Previously, I was a Forbes HBCU Scholar writing under the innovation and health and science teams.
Read more »
GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study SuggestsI'm a Texas native covering the latest trends in tech, science and healthcare through explainer pieces on the breaking news team. Previously, I was a Forbes HBCU Scholar writing under the innovation and health and science teams.
Read more »
New Study Reveals Detailed Protein Structure of Bitter Taste ReceptorResearchers have discovered the protein structure of TAS2R14, a bitter taste receptor, and how bitter-tasting substances activate it. This breakthrough could pave the way for the development of drugs targeting taste receptors.
Read more »